Value of a Statistical Model Based on Four Kallikrein Markers in Blood, Commercially Available as 4Kscore, in All Reasonable Prostate Biopsy Subgroups-Reference-Cited by-同舟云学术

Value of a Statistical Model Based on Four Kallikrein Markers in Blood, Commercially Available as 4Kscore, in All Reasonable Prostate Biopsy Subgroups

Published:2018-10 Issue:4 Volume:74 Page:535-536
ISSN:0302-2838
Container-title:European Urology
language:en
Short-container-title:European Urology

Author:

Vickers Andrew J.,Vertosick Emily A.,Sjoberg Daniel D.

Publisher

Elsevier BV

Subject

Urology

Reference5 articles.

1. Clinical performance of the 4Kscore test to predict high-grade prostate cancer at biopsy: a meta-analysis of US and European clinical validation study results;Zappala;Rev Urol,2017

2. CGS Medicare. Response to comments DL36979 MolDX: 4Kscore Assay 2017. https://cgsmedicare.com/articles/cope2063a.html.

3. Value of intact prostate specific antigen and human kallikrein 2 in the 4 kallikrein predictive model: an individual patient data meta-analysis;Vickers;J Urol,2018

4. Detection of high grade prostate cancer among PLCO participants using a prespecified 4-kallikrein marker panel;Kim;J Urol,2017

5. A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer screening in Rotterdam, Netherlands;Gupta;Br J Cancer,2010

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nomograms Combining PHI and PI-RADS in Detecting Prostate Cancer: A Multicenter Prospective Study;Journal of Clinical Medicine;2023-01-01

2. Methods Modernizing Statistical Reporting in Medical Journals: Challenges and Future Directions;European Urology;2022-12

3. Urinary Zinc Loss Identifies Prostate Cancer Patients;Cancers;2022-10-28

4. Predicting Grade group 2 or higher cancer at prostate biopsy by 4Kscore in blood and uCaP microRNA model in urine;Scientific Reports;2022-09-07

5. Liquid biomarkers for early detection of prostate cancer and summary of available data for their use in African-American men;Prostate Cancer and Prostatic Diseases;2022-03-04